辉瑞：准备好通过一切法律途径 以维护与Metséra协议项下的各项权利

Core Viewpoint - Pfizer (PFE.US) is prepared to pursue all legal avenues to protect its rights under the agreement with Metséra, indicating a strong stance against any potential challenges to its position [1] Group 1: Agreement and Legal Preparedness - Pfizer asserts that the proposal from Novo Nordisk does not meet the requirements for more favorable conditions as stipulated in the agreement with Metséra [1] - The company emphasizes its readiness to defend its rights legally, showcasing its commitment to the agreement [1] Group 2: Regulatory and Execution Risks - Novo Nordisk's acquisition of Metséra is highlighted to carry significant regulatory and execution risks, suggesting potential hurdles in the transaction process [1]